Skip to main content
. 2019 Jan 7;35(1):10–21. doi: 10.1093/arclin/acy101

Table 2.

Primary findings

FA MD AD RD
β p β p β p β p
Fminor –.16 .29 .26 .08
L ATR –.30 .04* .11 .49 .02 .88 .15 .33
R ATR –.22 .16 .01 .97
L CCG –.23 .14 .11 .46
R CCG –.23 .13 .11 .49
L ILF –.31 .04* .20 .19 .05 .74 .27 .07
R ILF –.18 .25 .22 .16
L SLFp –.27 .07 .05 .75
R SLFp –.29 .06 .13 .41
L SLFt –.35 .02* .11 .48 –.35 .73 .20 .18
R SLFt –.22 .14 .04 .77
L UNC –.30 .05* .22 .14 .13 .39 .24 .10
R UNC –.07 .64 .13 .37

*p < .05.